High Throughput News and Research

RSS
seqWell and Element Biosciences partner to demonstrate sequencing performance of multiplexed plexWell technology with the AVITI System

seqWell and Element Biosciences partner to demonstrate sequencing performance of multiplexed plexWell technology with the AVITI System

A polymer-nanoparticle hydrogel to subcutaneously deliver broadly neutralizing antibodies against SARS-CoV-2

A polymer-nanoparticle hydrogel to subcutaneously deliver broadly neutralizing antibodies against SARS-CoV-2

Nexus Medical Labs receives FDA Emergency Use Authorization for SARS-CoV-2 test using the RHINOstic™ Automated Nasal Swab from Rhinostics

Nexus Medical Labs receives FDA Emergency Use Authorization for SARS-CoV-2 test using the RHINOstic™ Automated Nasal Swab from Rhinostics

New Spex NanoSNAP™ provides high performance measurements of nucleic acids and proteins in a snap

New Spex NanoSNAP™ provides high performance measurements of nucleic acids and proteins in a snap

After SARS-CoV-2 infection, anti-chemokine antibodies correlate with better outcomes

After SARS-CoV-2 infection, anti-chemokine antibodies correlate with better outcomes

New initiative aims to increase collaboration and accelerate high-impact cancer immunotherapy

New initiative aims to increase collaboration and accelerate high-impact cancer immunotherapy

Beckman Coulter Life Sciences announces contest, products for centrifugation milestone

Beckman Coulter Life Sciences announces contest, products for centrifugation milestone

Largest study to date on long COVID identifies a broad list of diagnoses

Largest study to date on long COVID identifies a broad list of diagnoses

Antifungal agent Bifonazole as an antiviral against SARS-CoV-2

Antifungal agent Bifonazole as an antiviral against SARS-CoV-2

bit.bio launches Huntington’s disease human cell model

bit.bio launches Huntington’s disease human cell model

miRNAs associated with varying clinical presentations of SARS-CoV-2

miRNAs associated with varying clinical presentations of SARS-CoV-2

SARS-CoV-2 Omicron BA.2.12.1, BA.4 and BA.5 subvariants are superior to their predecessors

SARS-CoV-2 Omicron BA.2.12.1, BA.4 and BA.5 subvariants are superior to their predecessors

Probenecid shows activity against respiratory syncytial virus

Probenecid shows activity against respiratory syncytial virus

Sartorius Launches the Octet® SF3 SPR System, Strengthening its Leadership in Advanced Label-Free Bioanalytics

Sartorius Launches the Octet® SF3 SPR System, Strengthening its Leadership in Advanced Label-Free Bioanalytics

Researchers use a systems biology approach to parse the genetic diversity of C. difficile

Researchers use a systems biology approach to parse the genetic diversity of C. difficile

Comparative analysis of transcriptional responses across 13 different vaccines

Comparative analysis of transcriptional responses across 13 different vaccines

Dotphoton and Hamamatsu Photonics are partnering to provide the ultimate raw image compression and address the ever-growing biomedical image data volume

Dotphoton and Hamamatsu Photonics are partnering to provide the ultimate raw image compression and address the ever-growing biomedical image data volume

Exploring Populations of B and T Cells in Lymph Nodes of Patients Diagnosed with COVID-19 via Microscopy and Image Analysis

Exploring Populations of B and T Cells in Lymph Nodes of Patients Diagnosed with COVID-19 via Microscopy and Image Analysis

Research identifies inadequate PPE management in COVID-19 testing centers as source of major cross-contamination

Research identifies inadequate PPE management in COVID-19 testing centers as source of major cross-contamination

Novel saliva immunoassays to detect prior SARS-CoV-2 infection

Novel saliva immunoassays to detect prior SARS-CoV-2 infection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.